Cardiovascular risk and psoriasis: Beyond the traditional risk factors

American Journal of Medicine

Volumn 127, Issue 1, 2014, Pages 12-18

  Coumbe, Ann G ^a   Pritzker, Marc R ^a   Duprez, Daniel A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Cardiovascular risk; Inflammation; Prevention; Psoriasis

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYANOCOBALAMIN; CYCLOSPORIN; FOLIC ACID; METHOTREXATE; METOPROLOL; PROPRANOLOL; PYRIDOXINE; RETINOID; TAR; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VITAMIN D;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE SEVERITY; HUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; REVIEW; RISK FACTOR;

EID: 84891631575     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2013.08.013     Document Type: Review

References (60)

1. F.O. Nestle, D.H. Kaplan, and J. Barker Psoriasis N Engl J Med 361 2009 496 509
2. A.B. Kimball, D. Gladman, and J.M. Gelfand et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening J Am Acad Dermatol 58 2008 1031 1042
3. J.M. Gelfand, R. Weinstein, and S.B. Porter et al. Prevalence and treatment of psoriasis in the United Kingdom: a population based study Arch Dermatol 141 2005 1537 1541
4. A.L. Neimann, S.B. Porter, and J.M. Gelfand Epidemiology of psoriasis Expert Rev Dermatol 1 2006 63 75
5. R.G. Langley, G.G. Krueger, and C.E. Griffiths Psoriasis: epidemiology, clinical features, and quality of life Ann Rheum Dis 64 Suppl 2 2005 ii18 25
6. J. De Korte, M.A.G. Sprangers, F.M.C. Mombers, and J.D. Bos Quality of life in patients with psoriasis: a systemic literature review J Invest Dermatol 9 2004 140 147
7. J.F. Fowler, M.S. Duh, and L. Rovba et al. The impact of psoriasis on health care costs and patient work loss J Acad Dermatol 59 2008 772 780
8. A.L. Neimann, D.B. Shin, and X. Wang et al. Prevalence of cardiovascular risk factors in patients with psoriasis J Am Acad Dermatol 55 2006 829 835
9. D.M. Sommer, S. Jenisch, and M. Suchan et al. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis Arch Dermatol Res 298 2006 321 328
10. E. Christophers Comorbidities in psoriasis Clin Dermatol 25 2007 529 534
11. C.J. McDonald, and P. Calabresi Psoriasis and occlusive vascular disease Br J Dermatol 99 1978 469 475
12. J.M. Gelfand, A.L. Neimann, and D.B. Shin et al. Risk of myocardial infarction in patients with psoriasis JAMA 296 2006 1735 1741
13. A.W. Armstrong, C.T. Harskamp, and E.J. Armstrong The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies J Hypertens 31 2013 433 443
14. A.B. Kimball, D. Robinson Jr., and Y. Wu et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002 Dermatology 217 2008 27 37
15. A.W. Armstrong, C.T. Harskamp, and L. Ledo et al. Coronary artery disease in patients with psoriasis referred for coronary angiography Am J Cardiol 109 2012 976 980
16. S. Prodanovich, R.S. Kirsner, and J.D. Kravetz et al. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality Arch Dermatol 145 2009 700 703
17. A.B. Kimball, A. Guerin, and D. Latremouille-Viau et al. Coronary heart disease and stroke risk in patients with psoriasis Am J Med 123 2010 350 357
18. O. Ahlehoff, G.H. Gislason, and C.H. Jorgensen et al. Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish nationwide cohort study Eur Heart J 33 2012 2054 2064
19. M.A. Lowes, A.M. Bowcock, and J.G. Krueger Pathogenesis and therapy of psoriasis Nature 445 2007 866 873
20. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
21. B.S. Baker, D.W. Brown, and V.A. Fischetti et al. Skin and T cell proliferative response to M protein and other cell wall and membrane proteins of group A streptococci in chronic plaque psoriasis Clin Exp Immunol 124 2001 516 521
22. S.J. Szabo, B.M. Sullivan, S.L. Peng, and L.H. Glimcher Molecular mechanisms regulating Th1 immune response Annu Rev Immunol 21 2003 713 758
23. Y. Cai, C. Fleming, and J. Yan New insights of T cells in the pathogenesis of psoriasis Cell Mol Immunol 9 2012 302 309
24. M.M. Elloso, M. Gomez-Angelats, and A.M. Fourie Targeting the Th17 pathway in psoriasis J Leukoc Biol 92 2012 1187 1197
25. X. Cheng, X. Yu, and Y.J. Ding et al. The Th17/Treg imbalance in patients with acute coronary syndrome Clin Immunol 127 2008 89 97
26. O.J. de Boer, J.J. van der Meer, and P. Teeling et al. Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions PLoS ONE 2 2007 e779
27. K.K. Parsi, E.A. Brezinski, and T.C. Lin et al. Are patients with psoriasis being screened for cardiovascular risk factors? a study of screening practices and awareness among primary care physicians and cardiologists J Am Acad Dermatol 67 2012 357 362
28. A.B. Kimball, P. Szapary, and U. Mrowietz et al. Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis J Am Acad Dermatol 67 2012 76 85
29. M. Wakkee, H.B. Thio, and E.P. Prens et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients Atherosclerosis 190 2007 1 9
30. S. Corbetta, R. Angioni, and A. Cattaneo et al. Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines Eur J Endocrinol 154 2006 83 86
31. S. Prodanovich, F. Ma, and J.R. Taylor et al. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis J Am Acad Dermatol 52 2005 262 267
32. W.G. Dixon, K.D. Watson, and M. Lunt et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register Arthritis Rheum 56 2007 2905 2912
33. L.T. Jacobsson, C. Turesson, and A. Gulfe et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis Ann Rheum Dis 66 2007 670 675
34. J.J. Wu, K.Y. Poon, J.C. Channual, and A.Y. Shen Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis Arch Dermatol 20 2012 1 7
35. G. Weitz-Schmidt, K. Welzenbach, and V. Brinkmann et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nat Med 7 2001 687 692
36. S. Youssef, O. Stuve, and J.C. Patarroyo et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverse paralysis in central nervous system autoimmune disease Nature 420 2002 78 84
37. Y.B. Brauchli, S.S. Jick, and C.R. Meier Statin use and risk of first-time psoriasis diagnosis J Am Acad Dermatol 65 2011 77 83
38. E.A. Abel, L.M. DiCicco, and E.K. Orenberg et al. Drugs in exacerbation of psoriasis J Am Acad Dermatol 15 1986 1007 1022
39. S. Halevy, and E.J. Feuerman Psoriasiform eruption induced by propranolol Cutis 24 1979 95 98
40. W.B. White, P. Schulman, and E.J. McCabe Psoriasiform reaction to atenolol Arch Dermatol 122 1986 857 858
41. H.A. Neumann, and T. van Joost Adverse reactions of the skin to metoprolol and other beta-adrenoreceptor blocking agents Dermatologica 162 1981 330 335
42. Y.B. Brauchli, S.S. Jick, F. Curtin, and C.R. Meier Association between beta-blockers, other antihypertensive drugs and psoriasis: population-based case-control study Br J Dermatol 158 2008 1299 1307
43. N. Tsankov, J. Kazandjieva, and K. Drenovska Drugs in exacerbation and provocation of psoriasis Clin Dermatol 16 1998 333 351
44. A.D. Cohen, D.Y. Bonneh, and H. Reuveni et al. Drug exposure and psoriasis vulgaris: case-control and case-crossover studies Acta Derm Venereol 85 2005 299 303
45. C. Marquart-Elbaz, E. Grosshans, M. Alt, and D. Lipsker Sartans, angiotensin II receptor antagonists, can induce psoriasis Br J Dermatol 147 2002 617 618
46. A.D. Cohen, M. Kagen, M. Friger, and S. Halevy Calcium channel blockers intake and psoriasis: a case-control study Acta Derm Venereol 81 2001 347 349
47. J. Wilkin Exacerbation of psoriasis during clonidine therapy Arch Dermatol 117 1981 4
48. C. Vlachopoulos, K. Aznaouridis, and C. Stefanadis Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis J Am Coll Cardiol 55 2010 1318 1327
49. J. Yeboah, R.L. McClelland, and T. Polonsky et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals JAMA 308 2012 788 795
50. P. Gisondi, F. Fantin, and M. Giglio et al. Chronic plaque psoriasis is associated with increased arterial stiffness Dermatology 218 2009 110 113
51. I. Ardic, M.G. Kaya, and M. Yarlioglues et al. Impaired aortic elasticity properties in normotensive patients with psoriasis Blood Press 19 2010 351 358
52. D.D. Balci, A. Balci, and S. Karazincir et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis J Eur Acad Dermatol Venereol 23 2009 1 6
53. P. Troitzsch, M.R. Paulista Markus, and M. Dorr et al. Psoriasis is associated with increased intima-media thickness-the Study of Health in Pomerania (SHIP) Atherosclerosis 225 2012 486 490
54. R.J. Ludwig, C. Herzog, and A. Rostock et al. Psoriasis: a possible risk factor for development of coronary artery calcification Br J Dermatol 156 2007 271 276
55. N. Al-Mutairi, S. Al-Farag, A. Al-Mutairi, and M. Al-Shiltawy Comorbidities associated with psoriasis: an experience from the Middle East J Dermatol 37 2010 146 155
56. A.D. Cohen, H. Gilutz, and Y. Henkin et al. Psoriasis and the metabolic syndrome Acta Derm Venereol 87 2007 506 509
57. T. Henseler, and E. Christophers Disease concomitance in psoriasis J Am Acad Dermatol 32 1995 982 986
58. L. Mallibris, O. Akre, and F. Granath et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients Eur J Epidemiol 19 2004 225 230
59. M. Wakkee, R.M. Herings, and T. Nijsten Psoriasis may note be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort J Invest Dermatol 130 2010 962 967
60. O. Ahlehoff, G.H. Gislason, and M. Charlot et al. Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study J Intern Med 270 2010 147 157